RPM program · Endocrinology

Type 2 diabetes

Continuous glucose data made the signal free. The scarce thing is the person who acts on it.

Diabetes is the condition where the data volume most exceeds the clinical bandwidth. A single CGM produces 288 readings a day and no clinic can read that. The work is compression: turn a month of sensor traffic into three numbers that determine one decision. Gathermed computes glucometrics on ingest and surfaces the decision, not the trace. The trace is there when someone wants it.
Type 2 diabetes · observed transmission profile Representative, not best case
Day 1Day 15Day 30
Transmitted days 0 / 30
Device supply code
Signal stack

What gets measured, from where, and why it earns its place

Every source is tagged at ingest as billable or context-only. Context-only data is clinically valuable and never enters a device-supply line.

Interstitial glucose
Continuous glucose monitor via aggregator or direct vendor interface
Time in range, coefficient of variation, and time below range. The mean is the least useful number a CGM produces.
Fingerstick glucose
Connected meter, for non-CGM patients
Still the majority of a typical primary care panel.
Blood pressure
Cellular cuff
Two thirds of this population is hypertensive. One enrollment, one device kit, one program.
Weight
Connected scale
Anchors the incretin conversation and catches the unintentional loss that means something else.
Escalation design

Thresholds, and who has to do something about them

Red marks a same-day or immediate pathway. Amber marks a review within the stated window. Each one is assigned to a named clinician with a response clock, not to a queue.

Any glucose < 54 mg/dL, or > 1% time below range
ResponseSame-day contact, regimen review
Time in range < 50% over 14 days
ResponseTitration review
Coefficient of variation > 36%
ResponseRegimen instability, review before escalating dose
Sensor gap > 48 hours
ResponseRe-engagement, supply check

What we will not oversell

If your patient is on an incretin for weight rather than glycemia, the program design changes and so does the track. See the obesity and incretin therapy page.

Program operation

How the month actually runs

Confirm the CGM or meter is a cleared device and the data path is automatic, not photographed.
One kit covering glucose, pressure, and weight. Enrollment friction is the whole battle.
Glucometrics computed nightly. Clinician sees a 14-day panel, not a scatter plot.
Titration decisions recorded against the panel that justified them.
Monthly management time and interactive communication logged.
Code path · CY2026

What this program can bill

Rates are national non-facility averages, rounded, for orientation. They vary by locality and payer. Verify against your fee schedule before you model revenue on them.

CodeWhat it coversNational avgCadence
99453Setup and patient education
One-time device setup and patient education per episode of care.
$22once per episode
99454Device supply, 16-30 days
Device supply with daily recordings or programmed alerts, 16 or more days of data in 30.
$52per 30 days
99445new 2026Device supply, 2-15 days
New for 2026. Device supply where 2 to 15 days of data were transmitted in 30. Paid at the same rate as 99454. Mutually exclusive with 99454.
$52per 30 days
99457Treatment management, first 20 min
Clinical staff or QHP time, 20 minutes, with at least one interactive communication.
$52per calendar month
99458Treatment management, each additional 20 min
Add-on to 99457. Reported per additional 20 minutes in the month.
$41per additional 20 min
99091Data collection and interpretation, 30 min
QHP collection and interpretation of physiologic data. Cannot be stacked with 99457/99458 for the same service period.
$58per 30 days

Diagnosis anchors

ICD-10-CMDescription
E11.9Type 2 diabetes mellitus without complications
E11.65Type 2 diabetes mellitus with hyperglycemia
E11.22Type 2 diabetes mellitus with diabetic chronic kidney disease

Illustrative anchors only. Code to the documented clinical picture, not to a list on a vendor website.

The rules that break programs

One billing clinician per 30-day episode. RPM and RTM are not additive in the same calendar month. Duration codes are mutually exclusive. Management time requires at least one real-time interactive communication. Medical necessity precedes enrollment.

Full rule set and calculator

Sponsor view

If you are a manufacturer looking at this condition

This is the most commercially crowded and most commercially valuable remote monitoring population in the country. What a sponsor can actually learn: time-to-effect on glycemic endpoints in real-world dosing, the shape of the discontinuation curve, and which side effects precede a stop. Relevant to GLP-1 and dual agonist programs, SGLT2 inhibitors, and basal insulin analogs.

Read this before you fund anything

Sponsor-funded monitoring that produces billable revenue for prescribers is remuneration to referral sources under the federal Anti-Kickback Statute. The structures that survive scrutiny keep the sponsor's data interest and the provider's billing interest completely separate. The three structures we will build, and the one we will not.

Questions

Type 2 diabetes monitoring, answered directly

Is CGM data enough on its own to bill RPM?
The device supply code needs a cleared device transmitting automatically, which a CGM satisfies. The management codes still need documented clinician time and an interactive communication.
Can we run one program for diabetes and hypertension together?
Yes, and you should. One episode, one billing clinician, one device-supply line per 30 days. You do not get two device-supply payments for two devices in the same month.